Sains Malaysiana 51(1)(2022): 175-186

http://doi.org/10.17576/jsm-2022-5101-14

P2Y Purinergic Receptor Signaling in Oral Squamous Cell Carcinoma Cell Lines and Its Role in Proliferation and Cisplatin-Mediated Apoptosis

(Isyarat Reseptor Purinergik P2Y dalam Titisan Sel Oral Skuamus Sel Karsinoma dan Peranannya dalam Proliferasi dan Apoptosis Didorong Cisplatin)

LOK MUN LAW¹, NORAZRINA AZMI¹, IAN CHARLES PATERSON^2,3 & PEI YUEN NG¹*

¹Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Federal Territory, Malaysia

²Department of Oral & Craniofacial Science, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Federal Territory, Malaysia

³Oral Cancer Research and Coordinating Centre, University of Malaya, 50603 Kuala Lumpur, Federal Territory, Malaysia

Diserahkan: 29 Ogos 2020/Diterima: 23 April 2021

ABSTRACT

Treatment of advanced stage oral squamous cell carcinoma (OSCC) often involves the use of chemotherapeutic agents, such as cisplatin. However, its use often results in therapeutic failure due to chemoresistance. This study focused on a class of purinergic receptors, namely P2Y, which are activated via interaction with extracellular nucleotides. The functional effects of P2Y receptor activation in OSCC cell lines as well as the signaling pathways involved were investigated. The expression of P2Y₂ receptors in histological sections of OSCC was studied due to its association with cancer. Activation of MAPK pathways via extracellular nucleotides were studied in OSCC cell lines, along with downstream effects such as proliferation and cisplatin-mediated apoptosis. Immunohistochemical staining of OSCC tissue samples showed loss of P2Y₂ expression as the disease progressed. Western blotting identified different MAPK signaling pathways were activated by extracellular nucleotides. Bromodeoxyuridine proliferation assays showed increased cellular proliferation in the OSCC cell lines H400 (p < 0.001) and SAS (p < 0.001) after 24 h treatment with ATP. However, the ability of extracellular nucleotides to activate multiple P2Y receptor subtypes may indicate the involvement of other subtypes aside from P2Y₂. Cisplatin-mediated apoptosis was enhanced in SAS cells co-treated with ATP (p < 0.001), while H376 (p < 0.001) showed reduction in the number of apoptotic cells and no significant changes were observed in H103. This study concluded that extracellular nucleotide on OSCC cell lines with different characterizations had varied downstream effects, which suggests the use of targeted therapy to specific individuals.

Keywords: Adenosine triphosphate; extracellular nucleotide; oral squamous cell carcinoma; P2Y; purinergic receptor

ABSTRAK

Rawatan karsinoma sel skuamus mulut (OSCC) peringkat lanjut selalunya melibatkan penggunaan agen kemoterapi seperti cisplatin. Akan tetapi, rawatan sering kali gagal disebabkan oleh kerintangan terhadap agen kemoterapi tersebut. Kajian ini menumpukan perhatian pada satu kelas reseptor purinergik iaitu P2Y kerana ia diaktifkan oleh interaksi dengan nukleotida ekstrasel. Pengekspresan reseptor P2Y₂ pada OSCC ditentukan dalam kajian histologi kerana ia sering dikaitkan dengan kanser. Pengaktifan tapak jalan MAPK oleh nukleotida ekstrasel juga dikaji dalam titisan sel OSCC, bersama dengan kesan hiliran seperti proliferasi dan apoptosis oleh cisplatin. Pewarnaan imunohistokimia menunjukkan penurunan pengekspresan P2Y₂ dengan perkembangan penyakit. Pemblotan Western juga menunjukkan pengaktifan tapak jalan MAPK yang berlainan dengan nukleotida yang digunakan. Ujian proliferasi juga menunjukkan peningkatan kadar proliferasi pada titisan sel OSCC H400 dan SAS selepas 24 jam rangsangan oleh nukleotida ekstrasel. Akan tetapi, kebolehan nukleotida ekstrasel untuk berinteraksi dengan golongan subjenis reseptor P2Y berkemungkinan menunjukkan kesan yang dikaji melibatkan reseptor selain daripada P2Y₂. Apoptosis oleh cisplatin ditingkatkan dalam titisan sel SAS selepas rangsangan nukleotida ekstrasel, manakala titisan sel H376 pula menunjukkan penurunan bilangan sel apoptosis. Hasil kajian ini mendapati bahawa titisan sel OSCC yang berlainan dari segi penciriannya mempunyai kesan hiliran yang berbeza dan ini mencadangkan rawatan khusus yang disasarkan terhadap individu.

Kata kunci: Adenosina trifosfat; karsinoma sel skuamus mulut; nukleotida ekstrasel; P2Y; reseptor purinergik

RUJUKAN

Ab Manan, A., Ibrahim Tamin, N.S., Abdullah, H., Zainal Abidin, A. & Wahab, M. 2015. Malaysian National Cancer Registry Report 2007-2011. Putrajaya: Ministry of Health Malaysia.

Allard, B., Longhi, M.S., Robson, S.C. & Stagg, J. 2017. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunological Reviews 276(1): 121-144.

Bellefeuille, S.D., Molle, C.M. & Gendron, F.P. 2019. Reviewing the role of P2Y receptors in specific gastrointestinal cancers. Purinergic Signalling 15(4): 451-463.

Bhargava, S., Hotz, B., Hines, O.J., Reber, H.A., Buhr, H.J. & Hotz, H.G. 2007. Suramin inhibits not only tumor growth and metastasis but also angiogenesis in experimental pancreatic cancer. Journal of Gastrointestinal Surgery 11(2): 171-178.

Chinn, S.B. & Myers, J.N. 2015. Oral cavity carcinoma: Current management, controversies, and future directions. Journal of Clinical Oncology 33(29): 3269-3276.

Di Virgilio, F. & Adinolfi, E. 2017. Extracellular purines, purinergic receptors and tumor growth. Oncogene 36(3): 293-303.

Elliott, M.R., Chekeni, F.B., Trampont, P.C., Lazarowski, E.R., Kadl, A., Walk, S.F., Park, D., Woodson, R.I., Ostankovich, M., Sharma, P., Lysiak, J.J., Harden, T.K., Leitinger, N. & Ravichandran, K.S. 2009. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461(7261): 282-286.

Falzoni, S., Donvito, G. & Di Virgilio, F. 2013. Detecting adenosine triphosphate in the pericellular space. Interface Focus 3(3): 20120101.

Florea, A.M. & Busselberg, D. 2011. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3(1): 1351-1371.

Ge, X., Fu, Y.M. & Meadows, G.G. 2002. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells. Cancer Letters 179(2): 133-140.

Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., Perfettini, J.L., Schlemmer, F., Tasdemir, E., Uhl, M., Genin, P., Civas, A., Ryffel, B., Kanellopoulos, J., Tschopp, J., Andre, F., Lidereau, R., McLaughlin, N.M., Haynes, N.M., Smyth, M.J., Kroemer, G. & Zitvogel, L. 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nature Medicine 15(10): 1170-1178.

Graf, K., Xi, X.P., Yang, D., Fleck, E., Hsueh, W.A. & Law, R.E. 1997. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 29(1): 334-339.

Gruenbacher, G., Gander, H., Rahm, A., Dobler, G., Drasche, A., Troppmair, J., Nussbaumer, W. & Thurnher, M. 2019. The human G protein-coupled ATP receptor P2Y11 is associated with IL-10 driven macrophage differentiation. Frontiers in Immunology 10: 1870.

Hopfner, M., Lemmer, K., Jansen, A., Hanski, C., Riecken, E.O., Gavish, M., Mann, B., Buhr, H., Glassmeier, G. & Scherubl, H. 1998. Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochemical and Biophysical Research Communications 251(3): 811-817.

Jacobson, K.A., Costanzi, S., Joshi, B.V., Besada, P., Shin, D.H., Ko, H., Ivanov, A.A. & Mamedova, L. 2006. Agonists and antagonists for P2 receptors. Novartis Foundation Symposia 276: 58-68.

Jacobson, K.A., Ivanov, A.A., de Castro, S., Harden, T.K. & Ko, H. 2009. Development of selective agonists and antagonists of P2Y receptors. Purinergic Signalling 5(1): 75-89.

James, G. & Butt, A.M. 2001. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium 30(4): 251-259.

Kauffenstein, G., Hechler, B., Cazenave, J.P. & Gachet, C. 2004. Adenine triphosphate nucleotides are antagonists at the P2Y receptor. Journal of Thrombosis and Haemostasis 2(11): 1980-1988.

Khoo, X.H., Paterson, I.C., Goh, B.H. & Lee, W.L. 2019. Cisplatin-resistance in oral squamous cell carcinoma: Regulation by tumor cell-derived extracellular vesicles. Cancers 11(8): 1166.

Kim, E.K. & Choi, E.J. 2010. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta 1802(4): 396-405.

Kim, M.S., Lee, E.J., Kim, H.R. & Moon, A. 2003. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Research 63(17): 5454-5461.

Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P. & Vandenabeele, P. 2012. Immunogenic cell death and DAMPs in cancer therapy. Nature Reviews Cancer 12(12): 860-875.

Krysko, O., Love Aaes, T., Bachert, C., Vandenabeele, P. & Krysko, D.V. 2013. Many faces of DAMPs in cancer therapy. Cell Death & Disease 4(5): e631.

Kuang, Y., Liu, H., Guo, S., Wang, Y., Zhang, H. & Qiao, Y. 2019. The antagonist of P2Y11 receptor NF157 ameliorates oxidized LDL-induced vascular endothelial inflammation. Artificial Cells, Nanomedicine, and Biotechnology 47(1): 1839-1845.

Li, W.H., Qiu, Y., Zhang, H.Q., Liu, Y., You, J.F., Tian, X.X. & Fang, W.G. 2013. P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. British Journal of Cancer 109(6): 1666-1675.

Maaser, K., Hopfner, M., Kap, H., Sutter, A.P., Barthel, B., von Lampe, B., Zeitz, M. & Scherubl, H. 2002. Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. British Journal of Cancer 86(4): 636-644.

Markopoulos, A.K. 2012. Current aspects on oral squamous cell carcinoma. The Open Dentistry Journal 6: 126-130.

Matsumoto, T., Yokote, K., Tamura, K., Takemoto, M., Ueno, H., Saito, Y. & Mori, S. 1999. Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. Journal of Biological Chemistry 274(20): 13954-13960.

Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V. & Di Virgilio, F. 2008. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE 3(7): e2599.

Prime, S.S., Nixon, S.V., Crane, I.J., Stone, A., Matthews, J.B., Maitland, N.J., Remnant, L., Powell, S.K., Game, S.M. & Scully, C. 1990. The behaviour of human oral squamous cell carcinoma in cell culture. The Journal of Pathology 160(3): 259-269.

Puchalowicz, K., Tarnowski, M., Baranowska-Bosiacka, I., Chlubek, D. & Dziedziejko, V. 2014. P2X and P2Y receptors-role in the pathophysiology of the nervous system. International Journal of Molecular Sciences 15(12): 23672-23704.

Rivera, C. 2015. Essentials of oral cancer. International Journal of Clinical and Experimental Pathology 8(9): 11884-11894.

Sacco, A.G. & Cohen, E.E. 2015. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. Journal of Clinical Oncology 33(29): 3305-3313.

Song, S., Jacobson, K.N., McDermott, K.M., Reddy, S.P., Cress, A.E., Tang, H., Dudek, S.M., Black, S.M., Garcia, J.G., Makino, A. & Yuan, J.X. 2016. ATP promotes cell survival via regulation of cytosolic [Ca²⁺] and Bcl-2/Bax ratio in lung cancer cells. American Journal of Physiology-Cell Physiology 310(2): C99-114.

Stagg, J. & Smyth, M.J. 2010. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29(39): 5346-5358.

Trabanelli, S., Ocadlikova, D., Gulinelli, S., Curti, A., Salvestrini, V., Vieira, R.P., Idzko, M., Di Virgilio, F., Ferrari, D. & Lemoli, R.M. 2012. Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation. The Journal of Immunology 189(3): 1303-1310.

Wang, B., Zhang, S., Yue, K. & Wang, X.D. 2013. The recurrence and survival of oral squamous cell carcinoma: A report of 275 cases. Chinese Journal of Cancer 32(11): 614-618.

Wang, Q., Gao, P., Wang, X. & Duan, Y. 2014. The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Scientific Reports 4(1): 1-9.

Xie, R., Xu, J., Wen, G., Jin, H., Liu, X., Yang, Y., Ji, B., Jiang, Y., Song, P., Dong, H. & Tuo, B. 2014. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP. Journal of Biological Chemistry 289(27): 19137-19149.

Xu, J., Vilanova, G. & Gomez, H. 2016. A mathematical model coupling tumor growth and angiogenesis. PLoS ONE 11(2): e0149422.

Yang, H., Geng, Y.H., Wang, P., Yang, H., Zhou, Y.T., Zhang, H.Q., He, H.Y., Fang, W.G. & Tian, X.X. 2020. Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling. Oncogene 39(35): 5795-5810.

Yang, X., Zhu, L., Lin, J., Liu, S., Luo, H., Mao, J., Nie, S., Chen, L. & Wang, L. 2015. Cisplatin activates volume-sensitive like chloride channels via purinergic receptor pathways in nasopharyngeal carcinoma cells. The Journal of Membrane Biology 248(1): 19-29.

Yegutkin, G.G. 2014. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities. Critical Reviews in Biochemistry and Molecular Biology 49(6): 473-497.

*Pengarang untuk surat-menyurat; email: pyng@ukm.edu.my